Development of Plasmodium-specific liver-resident memory CD8+ T cells after heat-killed sporozoite immunization in mice
© 2021 Wiley-VCH GmbH..
Malaria remains a major cause of mortality in the world and an efficient vaccine is the best chance of reducing the disease burden. Vaccination strategies for the liver stage of disease that utilise injection of live radiation-attenuated sporozoites (RAS) confer sterile immunity, which is mediated by CD8+ memory T cells, with liver-resident memory T cells (TRM ) being particularly important. We have previously described a TCR transgenic mouse, termed PbT-I, where all CD8+ T cells recognize a specific peptide from Plasmodium. PbT-I form liver TRM cells upon RAS injection and are capable of protecting mice against challenge infection. Here, we utilize this transgenic system to examine whether nonliving sporozoites, killed by heat treatment (HKS), could trigger the development of Plasmodium-specific liver TRM cells. We found that HKS vaccination induced the formation of memory CD8+ T cells in the spleen and liver, and importantly, liver TRM cells were fewer in number than that induced by RAS. Crucially, we showed the number of TRM cells was significantly higher when HKS were combined with the glycolipid α-galactosylceramide as an adjuvant. In the future, this work could lead to development of an antimalaria vaccination strategy that does not require live sporozoites, providing greater utility.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
---|---|
Enthalten in: |
European journal of immunology - 51(2021), 5 vom: 30. Mai, Seite 1153-1165 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ghilas, Sonia [VerfasserIn] |
---|
Links: |
---|
Themen: |
CD8+ T cells |
---|
Anmerkungen: |
Date Completed 27.09.2021 Date Revised 27.09.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/eji.202048757 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320488993 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320488993 | ||
003 | DE-627 | ||
005 | 20231225173707.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/eji.202048757 |2 doi | |
028 | 5 | 2 | |a pubmed24n1068.xml |
035 | |a (DE-627)NLM320488993 | ||
035 | |a (NLM)33486759 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ghilas, Sonia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Development of Plasmodium-specific liver-resident memory CD8+ T cells after heat-killed sporozoite immunization in mice |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.09.2021 | ||
500 | |a Date Revised 27.09.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 Wiley-VCH GmbH. | ||
520 | |a Malaria remains a major cause of mortality in the world and an efficient vaccine is the best chance of reducing the disease burden. Vaccination strategies for the liver stage of disease that utilise injection of live radiation-attenuated sporozoites (RAS) confer sterile immunity, which is mediated by CD8+ memory T cells, with liver-resident memory T cells (TRM ) being particularly important. We have previously described a TCR transgenic mouse, termed PbT-I, where all CD8+ T cells recognize a specific peptide from Plasmodium. PbT-I form liver TRM cells upon RAS injection and are capable of protecting mice against challenge infection. Here, we utilize this transgenic system to examine whether nonliving sporozoites, killed by heat treatment (HKS), could trigger the development of Plasmodium-specific liver TRM cells. We found that HKS vaccination induced the formation of memory CD8+ T cells in the spleen and liver, and importantly, liver TRM cells were fewer in number than that induced by RAS. Crucially, we showed the number of TRM cells was significantly higher when HKS were combined with the glycolipid α-galactosylceramide as an adjuvant. In the future, this work could lead to development of an antimalaria vaccination strategy that does not require live sporozoites, providing greater utility | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a CD8+ T cells | |
650 | 4 | |a Liver | |
650 | 4 | |a Plasmodium | |
650 | 4 | |a Sporozoites | |
650 | 4 | |a Vaccination | |
650 | 7 | |a Malaria Vaccines |2 NLM | |
650 | 7 | |a Vaccines, Inactivated |2 NLM | |
700 | 1 | |a Enders, Matthias H |e verfasserin |4 aut | |
700 | 1 | |a May, Rose |e verfasserin |4 aut | |
700 | 1 | |a Holz, Lauren E |e verfasserin |4 aut | |
700 | 1 | |a Fernandez-Ruiz, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Cozijnsen, Anton |e verfasserin |4 aut | |
700 | 1 | |a Mollard, Vanessa |e verfasserin |4 aut | |
700 | 1 | |a Cockburn, Ian A |e verfasserin |4 aut | |
700 | 1 | |a McFadden, Geoffrey I |e verfasserin |4 aut | |
700 | 1 | |a Heath, William R |e verfasserin |4 aut | |
700 | 1 | |a Beattie, Lynette |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of immunology |d 1971 |g 51(2021), 5 vom: 30. Mai, Seite 1153-1165 |w (DE-627)NLM000108723 |x 1521-4141 |7 nnns |
773 | 1 | 8 | |g volume:51 |g year:2021 |g number:5 |g day:30 |g month:05 |g pages:1153-1165 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/eji.202048757 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 51 |j 2021 |e 5 |b 30 |c 05 |h 1153-1165 |